FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155014512> ?p ?o ?g. }

• W2155014512 endingPage "68" @default.
• W2155014512 startingPage "45" @default.
• W2155014512 abstract "Should patients with newly-diagnosed metastatic brain tumors undergo stereotactic radiosurgery (SRS) compared with other treatment modalities? Target population These recommendations apply to adults with newly diagnosed solid brain metastases amenable to SRS; lesions amenable to SRS are typically defined as measuring less than 3 cm in maximum diameter and producing minimal (less than 1 cm of midline shift) mass effect. Recommendations SRS plus WBRT vs. WBRT alone Level 1 Single-dose SRS along with WBRT leads to significantly longer patient survival compared with WBRT alone for patients with single metastatic brain tumors who have a KPS ≥ 70. Level 2 Single-dose SRS along with WBRT is superior in terms of local tumor control and maintaining functional status when compared to WBRT alone for patients with 1–4 metastatic brain tumors who have a KPS ≥ 70. Level 3 Single-dose SRS along with WBRT may lead to significantly longer patient survival than WBRT alone for patients with 2–3 metastatic brain tumors. Level 4 There is class III evidence demonstrating that single-dose SRS along with WBRT is superior to WBRT alone for improving patient survival for patients with single or multiple brain metastases and a KPS < 70. SRS plus WBRT vs. SRS alone Level 2 Single-dose SRS alone may provide an equivalent survival advantage for patients with brain metastases compared with WBRT + single-dose SRS. There is conflicting class I and II evidence regarding the risk of both local and distant recurrence when SRS is used in isolation, and class I evidence demonstrates a lower risk of distant recurrence with WBRT; thus, regular careful surveillance is warranted for patients treated with SRS alone in order to provide early identification of local and distant recurrences so that salvage therapy can be initiated at the soonest possible time. Surgical Resection plus WBRT vs. SRS ± WBRT Level 2 Surgical resection plus WBRT, vs. SRS plus WBRT, both represent effective treatment strategies, resulting in relatively equal survival rates. SRS has not been assessed from an evidence-based standpoint for larger lesions (>3 cm) or for those causing significant mass effect (>1 cm midline shift). Level 3: Underpowered class I evidence along with the preponderance of conflicting class II evidence suggests that SRS alone may provide equivalent functional and survival outcomes compared with resection + WBRT for patients with single brain metastases, so long as ready detection of distant site failure and salvage SRS are possible. SRS alone vs. WBRT alone Level 3 While both single-dose SRS and WBRT are effective for treating patients with brain metastases, single-dose SRS alone appears to be superior to WBRT alone for patients with up to three metastatic brain tumors in terms of patient survival advantage." @default.
• W2155014512 created "2016-06-24" @default.
• W2155014512 creator A5001528733 @default.
• W2155014512 creator A5002225991 @default.
• W2155014512 creator A5011967515 @default.
• W2155014512 creator A5012316455 @default.
• W2155014512 creator A5012323508 @default.
• W2155014512 creator A5013384985 @default.
• W2155014512 creator A5019173998 @default.
• W2155014512 creator A5020032572 @default.
• W2155014512 creator A5025281344 @default.
• W2155014512 creator A5027150108 @default.
• W2155014512 creator A5048176134 @default.
• W2155014512 creator A5054814683 @default.
• W2155014512 creator A5061676019 @default.
• W2155014512 creator A5066158171 @default.
• W2155014512 creator A5069699492 @default.
• W2155014512 creator A5078019479 @default.
• W2155014512 creator A5084093229 @default.
• W2155014512 creator A5088040279 @default.
• W2155014512 date "2009-12-04" @default.
• W2155014512 modified "2023-10-14" @default.
• W2155014512 title "The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline" @default.
• W2155014512 cites W1562627189 @default.
• W2155014512 cites W1964905218 @default.
• W2155014512 cites W1966459698 @default.
• W2155014512 cites W1968553915 @default.
• W2155014512 cites W1972923244 @default.
• W2155014512 cites W1973980909 @default.
• W2155014512 cites W1977666111 @default.
• W2155014512 cites W1980708038 @default.
• W2155014512 cites W1986254095 @default.
• W2155014512 cites W1995666732 @default.
• W2155014512 cites W1998488881 @default.
• W2155014512 cites W2002031619 @default.
• W2155014512 cites W2003917401 @default.
• W2155014512 cites W2004852620 @default.
• W2155014512 cites W2010731633 @default.
• W2155014512 cites W2011345687 @default.
• W2155014512 cites W2014745188 @default.
• W2155014512 cites W2018952014 @default.
• W2155014512 cites W2019695352 @default.
• W2155014512 cites W2028953164 @default.
• W2155014512 cites W2030841480 @default.
• W2155014512 cites W2032805380 @default.
• W2155014512 cites W2041146056 @default.
• W2155014512 cites W2041725096 @default.
• W2155014512 cites W2042027698 @default.
• W2155014512 cites W2047023120 @default.
• W2155014512 cites W2047930883 @default.
• W2155014512 cites W2060842923 @default.
• W2155014512 cites W2061962226 @default.
• W2155014512 cites W2069419936 @default.
• W2155014512 cites W2071990624 @default.
• W2155014512 cites W2075757784 @default.
• W2155014512 cites W2076229598 @default.
• W2155014512 cites W2078768340 @default.
• W2155014512 cites W2080075660 @default.
• W2155014512 cites W2083406155 @default.
• W2155014512 cites W2087641934 @default.
• W2155014512 cites W2088454694 @default.
• W2155014512 cites W2102968146 @default.
• W2155014512 cites W2104165122 @default.
• W2155014512 cites W2115886451 @default.
• W2155014512 cites W2121972475 @default.
• W2155014512 cites W2124662214 @default.
• W2155014512 cites W2128871519 @default.
• W2155014512 cites W2153022133 @default.
• W2155014512 cites W2158789700 @default.
• W2155014512 cites W2161744351 @default.
• W2155014512 cites W2162505942 @default.
• W2155014512 cites W2329793926 @default.
• W2155014512 cites W2442259061 @default.
• W2155014512 cites W2533301708 @default.
• W2155014512 cites W2766048157 @default.
• W2155014512 cites W340468752 @default.
• W2155014512 cites W35227811 @default.
• W2155014512 cites W4231427560 @default.
• W2155014512 cites W4243543845 @default.
• W2155014512 cites W4255038403 @default.
• W2155014512 doi "https://doi.org/10.1007/s11060-009-0073-4" @default.
• W2155014512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4969816" @default.
• W2155014512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19960227" @default.
• W2155014512 hasPublicationYear "2009" @default.
• W2155014512 type Work @default.
• W2155014512 sameAs 2155014512 @default.
• W2155014512 citedByCount "421" @default.
• W2155014512 countsByYear W21550145122012 @default.
• W2155014512 countsByYear W21550145122013 @default.
• W2155014512 countsByYear W21550145122014 @default.
• W2155014512 countsByYear W21550145122015 @default.
• W2155014512 countsByYear W21550145122016 @default.
• W2155014512 countsByYear W21550145122017 @default.
• W2155014512 countsByYear W21550145122018 @default.
• W2155014512 countsByYear W21550145122019 @default.
• W2155014512 countsByYear W21550145122020 @default.
• W2155014512 countsByYear W21550145122021 @default.
• W2155014512 countsByYear W21550145122022 @default.

• next